Welcome to our dedicated page for Owlet news (Ticker: OWLT), a resource for investors and traders seeking the latest updates and insights on Owlet stock.
Owlet Inc (OWLT) delivers innovative digital parenting solutions through smart baby monitors and health-tracking wearables. This news hub provides investors and caregivers with essential updates on the company’s advancements in infant care technology.
Access real-time information on product launches, financial results, and strategic partnerships directly from official sources. Our curated collection includes press releases, regulatory filings, and market developments relevant to Owlet’s IoT-enabled ecosystem.
Key updates cover earnings announcements, FDA clearances for medical devices, retail expansions, and sleep solution program enhancements. Stay informed about innovations in wearable vitals monitoring and cloud-based parenting platforms that define Owlet’s market position.
Bookmark this page for streamlined access to verified OWLT updates. Combine ongoing monitoring with historical context to track the company’s progress in transforming infant care through connected devices.
Owlet, Inc. (NYSE: OWLT) will release its Q1 2023 financial results on May 11, 2023, after market close. The announcement will be available via Business Wire and on Owlet’s Investor Relations website. Following the release, Owlet's President and CEO Kurt Workman and CFO Kate Scolnick will host a conference call at 4:30 p.m. ET to discuss the results and provide business updates. Investors can listen to the call by dialing (833) 470-1428 (domestic) or +1 (929) 526-1599 (international), referencing Access Code 581944. A replay will be available post-call. Owlet aims to empower parents with data-driven insights to enhance their parenting experience.
Owlet, Inc. (NYSE: OWLT) announced on April 4, 2023, that it received a notification from the New York Stock Exchange regarding non-compliance with listing standards. This occurred due to its average global market capitalization and stockholders’ equity falling below $50 million. The Company intends to submit a plan to the NYSE within 45 days to address this deficiency and aims to comply within an 18-month cure period. The notification does not immediately affect the listing of Owlet's Class A common stock, which will continue trading while the Company works on the plan. If the plan is not submitted or accepted, delisting proceedings could be initiated.